Companies  » Health Care

Cipla asks govt to revoke Novartis' patent; launches its drug

Taking the patent battle to Novartis, India's Cipla has launched low-cost generic version of the Swiss drug maker's respiratory drug Indacaterol ...

Neuland Labs down over 5% on profit taking

30 Oct 2014

The stock witnessed profit taking after rising nearly 17% ahead of its second quarter earnings

Dr Reddy's net slips 16.8%, blames tardy growth in US market

30 Oct 2014

Income from sales and services during the quarter grew by 6.9 per cent to Rs 3,588 crore

Dr Reddy's: Price erosion in US, rouble devaluation impact sales growth

29 Oct 2014

H2 expected to be better on back of launches, limited competition

Dr Reddy's Q2 net drops 17% to Rs 574 crore

29 Oct 2014

Income from sales and services grew by 7% at Rs 3,588 cr

Dr Reddy's Q2 profit falls 17% at Rs 574 crore

29 Oct 2014

Dr Reddy's Laboratories Ltd, India's second-largest drugmaker by revenue, reported a 17 percent drop in its second-quarter profit, pushing its ...

Jubilant Life Sciences slumps after Q2 loss widens

29 Oct 2014

The company reported a higher loss of Rs 94 crore in Jul-Sep quarter compared with Rs 81 crore in the same quarter last fiscal

Ranbaxy books first profit in six quarters, Q2 PAT at Rs 478 cr

29 Oct 2014

The drug maker, acquired by Sun Pharma, had a loss of Rs 454 cr in year ago quarter when it took a foreign exchange charge of Rs 360 cr

Lupin net up 55%, led by strong US & India sales

29 Oct 2014

Aims to prioritise acquisitions in US

Ranbaxy: Sustainable turnaround or a blip?

28 Oct 2014

September quarter numbers ahead of estimates, driven by Diovan exclusivity benefits

Dr Reddy's launches organ transplant drug in the US

28 Oct 2014

Hyderabad-based drug maker Dr Reddy's Laboratories stated that it has launched Sirolimus tablets 1 mg and 2 mg, a therapeutic equivalent generic ...

Jubilant Life Sciences reports Q2 net loss of Rs 94.11 crore

28 Oct 2014

Jubilant Life Sciences today posted a consolidated net loss of Rs 94.11 crore for the second quarter ended September 30, 2014.

Ranbaxy back in black with Q2 profit of Rs 478 cr

28 Oct 2014

Drug firm Ranbaxy Laboratories today reported a consolidated net profit of Rs 477.75 crore for the quarter ended September 30, 2014 on account ...

Ranbaxy rallies 6% as Q2 profit beats estimates

28 Oct 2014

The company reported consolidated net profit of Rs 478 crore in September quarter against loss of Rs 454 crore in year ago.

Lupin Q2 profit up 54% as US, India sales rise

28 Oct 2014

Generic drugmaker Lupin Ltd reported a 54 percent jump in second-quarter profit beating analysts estimates, helped by robust sales in its ...

Ranbaxy swings back into profit in Q2 at Rs 478 cr

28 Oct 2014

Consolidated revenue increases 16% to Rs 3,260 cr

Pharma companies' premium valuations to sustain

27 Oct 2014

Analysts say they will continue to sustain their 50% premium versus broader market as forthcoming Q2 results will be strong enough to sustain ...

Alembic Pharma picks up 49% equity in Algerian drug firm

27 Oct 2014

Announces entry into the the $3-bn worth Algerian market

Alembic to pick up 49% stake in Algeria's Adwiya Mami

27 Oct 2014

Drug firm Alembic Pharmaceuticals will acquire 49 per cent stake in Algeria-based Adwiya Mami SARL for an undisclosed sum as it seeks to enter ...

Quick Links


Back to Top